Last winter we reported the latest on important second-line medication treatments for glaucoma.

How do things stand nearly a year later? We caught up with a couple of experts at the American Academy of Ophthalmology’s 2019 annual meeting in San Francisco. Two important takeaways…

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Journal Scan

  1. Oct 25, 2019

Genetic Risk Scores With POAG Risk Variants Associated With Age at Diagnosis

A new study in JAMA Ophthalmology investigated if genetic risk scores comprising 12 primary open-angle glaucoma (POAG) risk variants were associated with age at diagnosis. Genetic variants influence disease risk but clinical effects of associated variants is unknown…